Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
3.
Br J Dermatol ; 185(1): 101-109, 2021 07.
Article in English | MEDLINE | ID: mdl-33454993

ABSTRACT

BACKGROUND: Whether melanoma in histological contiguity with a naevus [naevus-associated melanoma (NAM)] is distinctly different from melanoma arising de novo remains unclear. OBJECTIVES: To determine whether the characteristics of de novo melanoma differ from NAM and are not due to naevus obliteration in thicker tumours. METHODS: We conducted a multicentre retrospective study of de novo melanoma and NAM in seven referral centres in Europe, Australia and the USA between 2006 and 2015. RESULTS: In a total of 9474 localized melanomas, de novo melanoma was associated with thicker tumours and body site differences compared with NAM. In the subset of T1 melanomas (n = 5307), similar body site differences were found in multivariate analysis by body site. When compared with NAM, de novo melanoma was more likely to affect older individuals (≥ 70 years) when located on the head/neck [odds ratio (OR) 4·65, 95% confidence interval (CI) 2·55-8·46], the trunk (OR 1·82, 95% CI 1·40-2·36) or the upper extremity (OR 1·69, 95% CI 1·14-2·50), was more likely to affect female patients when located on the lower extremities (OR 1·36, 95% CI 1·03-1·80), and was more likely to be of the nodular melanoma subtype (OR 2·23, 95% CI 1·14-4·35) when located on the trunk. De novo melanoma was less likely to have regression present compared with NAM. CONCLUSIONS: Clinicopathological and body site differences between de novo melanoma and NAM support the divergent pathway model of development. These differences were also found in thin melanomas, suggesting that de novo melanomas are different from NAM and their differences are not due to the obliteration of naevus remnants in thicker tumours.


Subject(s)
Melanoma , Skin Neoplasms , Australia , Europe/epidemiology , Female , Humans , Melanoma/epidemiology , Retrospective Studies , Skin Neoplasms/epidemiology
11.
Acta Reumatol Port ; 38(2): 128-30, 2013.
Article in English | MEDLINE | ID: mdl-24141350

ABSTRACT

Fibroblastic rheumatism is a rare fibro-proliferative disease, of unknown etiology. It is characterized by sudden onset of symmetric inflammatory polyarthritis simultaneously or preceded by multiple cutaneous nodules, ranging from 5 to 20mm in diameter, with predilection for the upper and lower extremities. With only a few dozens of cases described, it has a worldwide distribution, affecting primarily caucasians of all ages (cases described ranging 8 to 68 years), without gender predilection. The authors describe the case of a patient presenting multiple cutaneous nodules located on the back of the hands, without any articular or sistemyc complaints. Correlation between clinical and histopathological aspects led to the diagnosis and treatment, with a favorable outcome.


Subject(s)
Rheumatic Diseases , Female , Humans , Middle Aged , Rheumatic Diseases/drug therapy , Rheumatic Diseases/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...